Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
152.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.20 (0.797%)
Market Cap: £1.58b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

STATEMENT FROM JD.COM

15 Mar 2024 14:01

RNS Number : 1032H
JD.com, Inc.
15 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

FOR IMMEDIATE RELEASE

 

15 MARCH 2024

 

STATEMENT FROM JD.COM ("JD.COM")

STATEMENT OF INTENTION NOT TO MAKE AN OFFER FOR CURRYS PLC ("CURRYS")

 

 

Further to the announcement on 19 February 2024 that JD.com was in the very preliminary stages of evaluating a possible transaction that may include a cash offer for the entire issued share capital of Currys, JD.com today confirms that, following careful consideration, it does not intend to make an offer for Currys.

 

This is a statement to which Rule 2.8 of the Code applies.

 

For the purposes of Note 2 on Rule 2.8 of the Code, JD.com and any person(s) acting in concert with it reserve the right to make or participate in an offer for Currys (and/or take any other actions which would otherwise be restricted under Rule 2.8 of the Code) within the next six months following the date of this announcement:

 

(i) with the agreement of Currys' Board;

 

(ii) following the announcement of a firm intention to make an offer for Currys by or on behalf of a third party;

 

(iii) following the announcement by Currys of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or

 

(iv) where the Takeover Panel has determined that there has been a material change of circumstances.

 

Enquiries:

 

Goldman Sachs International Tel: +4420 7774 1000

Andre Kelleners

Milan Hasecic

Chris Emmerson

 

Important notices

 

This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction.

The release, publication or distribution of this announcement in whole or in part in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

 

Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the UK, is acting exclusively for JD.com and no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than JD.com for providing the protections afforded to clients of Goldman Sachs International or for providing advice in connection with the matters referred to in this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDSFUFDIELSEID
Date   Source Headline
18th Jan 20247:00 amRNSStrengthening performance in a tough environment
2nd Jan 202412:52 pmRNSTotal Voting Rights
21st Dec 20232:54 pmRNSHolding(s) in Company
21st Dec 202310:40 amRNSHolding(s) in Company
20th Dec 20239:54 amRNSHolding(s) in Company
14th Dec 20235:24 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSSolid performance in a tough environment
1st Dec 20239:06 amRNSTotal Voting Rights
21st Nov 202312:01 pmRNSResult of Meeting
3rd Nov 202312:25 pmRNSShareholder Circular and Notice of General Meeting
3rd Nov 20237:05 amRNSProposed Disposal of Kotsovolos
1st Nov 20239:41 amRNSTotal Voting Rights
10th Oct 20237:27 amRNSUpdate on Strategic Review of Kotsovolos
6th Oct 20233:16 pmRNSHolding(s) in Company
2nd Oct 202311:26 amRNSTotal Voting Rights
28th Sep 202310:55 amRNSHolding(s) in Company
20th Sep 202310:35 amRNSDirector/PDMR Shareholding
19th Sep 202310:35 amRNSHolding(s) in Company
7th Sep 20231:51 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM Trading Statement
1st Sep 20239:09 amRNSTotal Voting Rights
22nd Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 202312:40 pmRNSDirector/PDMR Shareholding
4th Aug 20239:44 amRNSDirector/PDMR Shareholding
3rd Aug 202312:54 pmRNSAnnual Financial Report
3rd Aug 20239:25 amRNSDirector/PDMR Shareholding
1st Aug 202311:09 amRNSTotal Voting Rights
28th Jul 202310:58 amRNSDirector/PDMR Shareholding
13th Jul 20238:30 amRNSHolding(s) in Company
12th Jul 20234:14 pmRNSHolding(s) in Company
11th Jul 20239:42 amRNSHolding(s) in Company
10th Jul 20232:59 pmRNSDirector/PDMR Shareholding
7th Jul 202310:36 amRNSDirector/PDMR Shareholding
6th Jul 20231:26 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSStrengthening UK&I offset by poor Nordics
3rd Jul 20239:55 amRNSTotal Voting Rights
26th Jun 202312:14 pmRNSHolding(s) in Company
23rd Jun 20234:23 pmRNSHolding(s) in Company
22nd Jun 20239:22 amRNSHolding(s) in Company
19th Jun 20235:20 pmRNSHolding(s) in Company
19th Jun 20234:38 pmRNSHolding(s) in Company
16th Jun 20237:00 amRNSStrategic Review of Kotsovolos
2nd Jun 202310:37 amRNSDirectorate Change
1st Jun 20239:33 amRNSTotal Voting Rights
24th May 20238:37 amRNSResponse to ESA announcement
15th May 20237:00 amRNSTrading Statement
3rd May 20235:21 pmRNSHolding(s) in Company
2nd May 202311:43 amRNSTotal Voting Rights
11th Apr 20235:53 pmRNSHolding(s) in Company
5th Apr 202310:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.